3190 related articles for article (PubMed ID: 19053174)
1. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
Coppé JP; Patil CK; Rodier F; Sun Y; Muñoz DP; Goldstein J; Nelson PS; Desprez PY; Campisi J
PLoS Biol; 2008 Dec; 6(12):2853-68. PubMed ID: 19053174
[TBL] [Abstract][Full Text] [Related]
2. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen.
Coppé JP; Patil CK; Rodier F; Krtolica A; Beauséjour CM; Parrinello S; Hodgson JG; Chin K; Desprez PY; Campisi J
PLoS One; 2010 Feb; 5(2):e9188. PubMed ID: 20169192
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids suppress selected components of the senescence-associated secretory phenotype.
Laberge RM; Zhou L; Sarantos MR; Rodier F; Freund A; de Keizer PL; Liu S; Demaria M; Cong YS; Kapahi P; Desprez PY; Hughes RE; Campisi J
Aging Cell; 2012 Aug; 11(4):569-78. PubMed ID: 22404905
[TBL] [Abstract][Full Text] [Related]
6. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype.
Wiley CD; Schaum N; Alimirah F; Lopez-Dominguez JA; Orjalo AV; Scott G; Desprez PY; Benz C; Davalos AR; Campisi J
Sci Rep; 2018 Feb; 8(1):2410. PubMed ID: 29402901
[TBL] [Abstract][Full Text] [Related]
8. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
Malaquin N; Tu V; Rodier F
Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
[TBL] [Abstract][Full Text] [Related]
9. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.
Freund A; Patil CK; Campisi J
EMBO J; 2011 Apr; 30(8):1536-48. PubMed ID: 21399611
[TBL] [Abstract][Full Text] [Related]
10. Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells.
Perrott KM; Wiley CD; Desprez PY; Campisi J
Geroscience; 2017 Apr; 39(2):161-173. PubMed ID: 28378188
[TBL] [Abstract][Full Text] [Related]
11. Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms.
Beck J; Turnquist C; Horikawa I; Harris C
Carcinogenesis; 2020 Aug; 41(8):1017-1029. PubMed ID: 32619002
[TBL] [Abstract][Full Text] [Related]
12. Senescent Breast Luminal Cells Promote Carcinogenesis through Interleukin-8-Dependent Activation of Stromal Fibroblasts.
Al-Khalaf HH; Ghebeh H; Inass R; Aboussekhra A
Mol Cell Biol; 2019 Jan; 39(2):. PubMed ID: 30397077
[TBL] [Abstract][Full Text] [Related]
13. The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.
Higashiguchi M; Murakami H; Akita H; Kobayashi S; Takahama S; Iwagami Y; Yamada D; Tomimaru Y; Noda T; Gotoh K; Doki Y; Yamamoto T; Eguchi H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999632
[TBL] [Abstract][Full Text] [Related]
14. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
[TBL] [Abstract][Full Text] [Related]
15. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence.
Coppé JP; Kauser K; Campisi J; Beauséjour CM
J Biol Chem; 2006 Oct; 281(40):29568-74. PubMed ID: 16880208
[TBL] [Abstract][Full Text] [Related]
16. Redox control of the senescence regulator interleukin-1α and the secretory phenotype.
McCarthy DA; Clark RR; Bartling TR; Trebak M; Melendez JA
J Biol Chem; 2013 Nov; 288(45):32149-32159. PubMed ID: 24062309
[TBL] [Abstract][Full Text] [Related]
17. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging.
Krtolica A; Parrinello S; Lockett S; Desprez PY; Campisi J
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12072-7. PubMed ID: 11593017
[TBL] [Abstract][Full Text] [Related]
18. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress-induced inhibition of Sirt1 by caveolin-1 promotes p53-dependent premature senescence and stimulates the secretion of interleukin 6 (IL-6).
Volonte D; Zou H; Bartholomew JN; Liu Z; Morel PA; Galbiati F
J Biol Chem; 2015 Feb; 290(7):4202-14. PubMed ID: 25512378
[TBL] [Abstract][Full Text] [Related]
20. The protein kinase D1-mediated classical protein secretory pathway regulates the Ras oncogene-induced senescence response.
Su Y; Wang P; Shen H; Sun Z; Xu C; Li G; Tong T; Chen J
J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29420297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
